Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Opportunities and Catalysts Integrated Care Scaling: As more patients move into IKC contracts, DaVitas ability to capture "shared savings" from the government could lead to further margin expansion
As competitive as the obesity drug market has become, Novo Nordisk's decision to slash the prices of its GLP-1 agonist drugs could put it back on the right track
This dual approach gives tirzepatide a higher level of effectiveness in controlling blood sugar and promoting fat loss than semaglutide
The study, reportedly the first of its kind, considered data from a National Institutes of Health research program that linked participant records with fitness tracker activity
US$ 22.31
US$ 22.11
US$ 29.55
US$ 27.70
US$ 29.22
US$ 24.51
US$ 21.25
